Advertisements



We are Sorry, This Page doesn't Exist


Vertex"s Cystic Fibrosis Drug Gets FDA Nod for Children

Vertex's (VRTX) cystic fibrosis drug, Kalydeco gets FDA approval to treat children aged 12 months to two years .....»»

Category: personnelSource: nytAug 16th, 2018

Vertex announces FDA approval of ORKAMBI to treat cystic fibrosis

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 7th, 2018

Vertex completes enrollment of two Phase 3 studies of cystic fibrosis candidate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 6th, 2018

Vertex Hits The Top, As Competitor Galapagos Doesn"t Impress In Cystic Fibrosis Study

Vertex Hits The Top, As Competitor Galapagos Doesn"t Impress In Cystic Fibrosis Study.....»»

Category: topSource: seekingalphaJul 2nd, 2018

Arrowhead presents new data on ARO-ENac for treatment of Cystic Fibrosis

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 21st, 2018

Vertex Hits Stumbling Block For One Triple-Combo Therapy For Cystic Fibrosis

Vertex Hits Stumbling Block For One Triple-Combo Therapy For Cystic Fibrosis.....»»

Category: topSource: seekingalphaApr 30th, 2018

Diffusion Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

Highlights Include FDA Approval of Phase 2 On-Ambulance Clinical Trial for Treatment of Stroke and Appointment of New Chief Financial Off.....»»

Category: earningsSource: benzingaNov 14th, 2018

AbbVie to assume full development, control of cystic fibrosis research program

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 24th, 2018

How Proteostasis Will Capitalize on Its Big Cystic Fibrosis Win

Proteostasis Therapeutics shares pulled back on Tuesday after the company announced that it would be conducting a secondary offering......»»

Category: blogSource: 247wallstOct 23rd, 2018

Proteostasis Therapeutics Surges On Cystic Fibrosis Data, Can The Run Continue?

Proteostasis Therapeutics Surges On Cystic Fibrosis Data, Can The Run Continue?.....»»

Category: topSource: seekingalphaOct 22nd, 2018

Why Proteostasis Therapeutics Tumbled 23.2% on Friday

Some investors booked profits following the company's recent cystic fibrosis trial data......»»

Category: topSource: foxnewsOct 19th, 2018

Vertex presents data at NACFC demonstrating progress for CF treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 18th, 2018

Why Proteostasis Shares Are Skyrocketing

Proteostasis Therapeutics shares absolutely exploded on Thursday after the company announced positive preliminary results from its early-stage cystic fibrosis trial......»»

Category: blogSource: 247wallstOct 18th, 2018

Ultragenyx announces approval of Mepsevii in Brazil for treatment of MPS VII

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 18th, 2018

Waltham"s Morphic Therapeutic inks $100M deal with AbbVie

A preclinical Waltham biotech company is hoping to launch its first clinical trial of a fibrosis treatment next year after signing a $100 million collaboration agreement with AbbVie this week. Morphic Therapeutic is partnering with AbbVie to devel.....»»

Category: topSource: bizjournalsOct 18th, 2018

CRISPR Wins FDA Approval for Human Trials

CRISPR Therapeutics shares made a handy gain on Thursday after the company announced a key FDA decision concerning its collaboration with Vertex Pharmaceuticals......»»

Category: blogSource: 247wallstOct 11th, 2018

AbbVie"s Orilissa Gets Canadian Nod to Treat Endometriosis

AbbVie (ABBV) and Neurocrine receive Canadian approval for Orilissa, for the treatment of moderate to severe pain associated with endometriosis. AbbVie ABBV along with its .....»»

Category: smallbizSource: nytOct 8th, 2018

Cambridge"s Akcea rebounds with FDA approval of first drug

After having one of its drugs rejected by the FDA in August, Cambridge biotech Akcea Therapeutics Inc. turned the tide on Friday, receiving approval for another treatment for a rare genetic disease. The FDA approved Tegsedi, known generically as ino.....»»

Category: topSource: bizjournalsOct 5th, 2018

CDEC recommends Vertex drug not be reimbursed for treatment of CF

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 5th, 2018

Roche"s Hemlibra Receives FDA Approval for Label Expansion

Roche (RHHBY) obtains the FDA approval for the label expansion of Hemlibra for the treatment of adults and children suffering haemophilia A without factor VIII inhibitors. .....»»

Category: worldSource: nytOct 5th, 2018